ICD-9-CM Volume 2 Index entries containing back-references to
286.5:
- Anticoagulant, intrinsic, circulating, causing hemorrhagic disorder (see also Circulating anticoagulants) 286.5
- Antithrombinemia (see also Circulating anticoagulants) 286.5
- Antithromboplastinemia (see also Circulating anticoagulants) 286.5
- Antithromboplastinogenemia (see also Circulating anticoagulants) 286.5
- Circulating, intrinsic anticoagulants causing hemorrhagic disorder 286.5
- following childbirth 666.3
- Disorder - see also Disease
- hemorrhagic NEC 287.9
- due to intrinsic circulating anticoagulants 286.5
- specified type NEC 287.8
- Hemophilia (familial) (hereditary) 286.0
- acquired 286.5
- secondary 286.5
- Hemorrhage, hemorrhagic (nontraumatic) 459.0
- disorder 287.9
- due to intrinsic circulating anticoagulants 286.5
- specified type NEC 287.8
- due to
- any device, implant, or graft (presence of) classifiable to 996.0-996.5 - see Complications, due to (presence of) any device, implant, or graft classified to 996.0-996.5 NEC
- intrinsic circulating anticoagulant 286.5
- Hyperheparinemia (see also Circulating anticoagulants) 286.5
- Increase, increased
- anticoagulants (antithrombin) (anti-VIIIa) (anti-IXa) (anti-Xa) (anti-XIa) 286.5
- Inhibitor, systemic lupus erythematosus (presence of) 286.5
- Lupus 710.0
- erythematosus (discoid) (local) 695.4
- System, systemic - see also condition
- lupus erythematosus 710.0
- inhibitor 286.5